Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
The Journal of Infectious Diseases|September 30, 2016
Cigarette Smoking and Inflammation, Monocyte Activation, and Coagulation in HIV-Infected Individuals Receiving Antiretroviral Therapy, Compared With Uninfected IndividualsKatherine W Kooij, Ferdinand W N M Wit, Thijs Booiman, et al.
The Lancet. HIV|August 29, 2024
Real-world effectiveness and tolerability of switching to doravirine-based antiretroviral therapy in people with HIV: a nationwide, matched, prospective cohort studyPatrick G A Oomen, Ferdinand W N M Wit, Kees Brinkman, et al.
AIDS (London, England)|December 20, 2015
HIV infection is independently associated with frailty in middle-aged HIV type 1-infected individuals compared with similar but uninfected controlsKatherine W Kooij, Ferdinand W N M Wit, Judith Schouten, et al.
The Lancet. HIV|January 14, 2023
Effect of the introduction of screening for cancer precursor lesions on anal cancer incidence over time in people living with HIV: a nationwide cohort studyRamon P van der Zee, Ferdinand W N M Wit, Olivier Richel, et al.
AIDS (London, England)|November 22, 2023
Screening for tuberculosis infection and effectiveness of preventive treatment among people with HIV in low-incidence settingsDorine van Geuns, Rob J W Arts, Gerard de Vries, et al.
The Journal of Infectious Diseases|September 22, 2017
Higher Prevalence and Faster Progression of Chronic Kidney Disease in Human Immunodeficiency Virus-Infected Middle-Aged Individuals Compared With Human Immunodeficiency Virus-Uninfected ControlsKatherine W Kooij, Liffert Vogt, Ferdinand W N M Wit, et al.
Antiviral Therapy|May 17, 2007
A phase I/IIa study with succinylated human serum albumin (Suc-HSA), a candidate HIV-1 fusion inhibitorJoost N Vermeulen, Dirk K F Meijer, Jan Over, et al.
Plos One|April 5, 2014
Temporary treatment during primary HIV infection does not affect virologic response to subsequent long-term treatmentMarlous L Grijsen, Ferdinand W N M Wit, Suzanne Jurriaans, et al.
Antiviral Therapy|August 23, 2012
No advantage of quadruple- or triple-class antiretroviral therapy as initial treatment in patients with very high viraemiaMarlous L Grijsen, Rebecca Holman, Luuk Gras, et al.
Sexually Transmitted Diseases|February 11, 2015
The impact of hormonal contraception and pregnancy on sexually transmitted infections and on cervicovaginal microbiota in african sex workersHanneke Borgdorff, Marijn C Verwijs, Ferdinand W N M Wit, et al.
Pageof 9